10% owner HRT Financial LP bought 32,591 shares ($110.7K) on Jun 29-30 at $3.40 avg, stock down -93.9% from $55.90 52-wk high
HRT Financial LP, a 10% owner of Shuttle Pharmaceuticals, made two open-market purchases totaling 32,591 shares for $110,694.49 on June 29–30, 2026, increasing its holdings by 70.8% from 46,006 shares to 78,597 shares. The timing coincides with severe price deterioration: the stock trades at $3.40, down -93.9% from its 52-week high of $55.90, with a 30-day decline of -36.2% and 90-day decline of -55.2%. The company is unprofitable, reporting net income of $-2,152,471.00 over its most recent full fiscal year. Across all open-market activity, the insider's track record shows 14 prior buys and 6 prior sells, indicating a pattern of accumulation. This purchase after a sharp drawdown warrants careful review of whether it reflects informed conviction or exposure to further downside risk in an unprofitable micro-cap.